Transcriptomic analysis of mice bearing a triple-negative breast cancer with an acquired resistance to anti-EGFR CAR T cells showed that treatment with EGFR-specific CAR T cells induced immunosuppressive genes that were associated with CAR T cell-activated enhancers [112]. Here, EGFR is linked to triple-negative breast carcinoma.